Categories: HealthcareNews

Zepp Clarity Introduces “Try Before You Buy” OTC Hearing Aids Program at CES 2025, Empowering Consumers with Confidence and Convenience

MILPITAS, Calif., and LAS VEGAS, Jan. 6, 2025 /PRNewswire/ — Zepp Clarity, the smart hearing solutions brand owned by Zepp Health (NYSE: ZEPP), a health technology company, today unveiled its innovative “Try Before You Buy” program at CES 2025. This initiative addresses a critical gap in hearing aid adoption by encouraging the older population to explore hearing solutions in a low-pressure, hands-on environment.

Despite the widespread prevalence of disabling age-related hearing loss, industry surveys and epidemiological studies have consistently documented that only 15% to 30% of adults with mild-to-moderate hearing loss obtain hearing aids. Many cite uncertainty about their effectiveness or discomfort with the commitment as barriers to adoption.

The “Try Before You Buy” model empowers individuals to experience the transformative benefits of Zepp Clarity’s advanced hearing solutions firsthand, boosting confidence and encouraging greater utilization of hearing aids.

With three state-of-the-art models—Clarity Omni, Clarity One, and Clarity PixieZepp Clarity is redefining hearing care by offering consumers the opportunity to experience advanced hearing solutions through a trial period in their homes.

Zepp Clarity provides a lifetime customer support guarantee and access to certified audiologists to its users, ensuring professional guidance and peace of mind for every customer.

Zepp Clarity Pixie, A Nearly Invisible Hearing Aid Providing A Leap Forward in Technology

At the forefront of Zepp Clarity’s offerings is the Zepp Clarity Pixie, a next-generation hearing aid solution designed for individuals with mild to moderate hearing impairment. The Pixie redefines the hearing aid experience with a nearly invisible design, seamless wireless connectivity, and a lightweight titanium alloy shell. Additional features include IPX7 water resistance, an impressive 17-hour battery life, and the ability to customize settings through the Zepp Clarity App, offering eight unique programs tailored to individual preferences.

The Pixie also includes innovative functionalities such as Clarity Boost, Smart Phone Call support, and a handy Find Device feature, ensuring users can navigate their daily routines with confidence and convenience. With a suggested retail price of $1,499, the Zepp Clarity Pixie is now available at https://clarity.zepp.com.

Empowering Hearing Health for All

Hearing loss impacts 48 million Americans and nearly 430 million people worldwide, yet adoption rates for hearing aids remain low. Zepp Clarity’s mission is to address this critical health challenge by combining cutting-edge wearable technology with expert audiology insights.

Registered as FDA-Exempt Class II medical devices, Zepp Clarity’s hearing aids are meticulously designed to offer discreet, high-performance solutions for adults aged 18 and older, enhancing both their hearing and overall wellness.

About Zepp Clarity

Zepp Clarity, a smart hearing solutions brand under Zepp Health, empowers individuals to live their healthiest lives. Guided by the belief that hearing health is integral to total wellness, Zepp Clarity leverages advanced hearable technologies, AI healthcare algorithms, and the expertise of leading audiologists to create personalized, high-performance hearing systems.

For more information about Zepp Clarity, visit https://clarity.zepp.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/zepp-clarity-introduces-try-before-you-buy-otc-hearing-aids-program-at-ces-2025-empowering-consumers-with-confidence-and-convenience-302342231.html

SOURCE Zepp Health

Staff

Recent Posts

DiagnosTear Signs Non-Binding Term Sheet with Sheba Impact and Ramot to Exclusively License New Eye Imaging Technology, CLARIFY, Enabling Needle-Free Blood Count

Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…

2 hours ago

CranioSense Awarded $5.5 Million in Federal Grants to Validate Noninvasive Neurotech

BOSTON, Dec. 17, 2025 /PRNewswire/ -- CranioSense, Inc., a neurotechnology company developing the world's first noninvasive…

2 hours ago

Therap Services Announces 2026 National Conference Schedule: Highlighting New Tools, Best Practices, and Over 250 Specialized Sessions

TORRINGTON, Conn., Dec. 17, 2025 /PRNewswire/ -- Therap Services, the national leader in HIPAA-compliant electronic…

2 hours ago

Catalyst by Wellstar Launches Polysight, Bringing Real-Time AI to Healthcare Compliance

The startup was formed to address rising regulatory complexity in healthcare.ATLANTA, Dec. 17, 2025 /PRNewswire/…

2 hours ago

Rockbridge Growth Equity-backed ProSites Acquires GeniusVets, Creating a Comprehensive Veterinary Marketing Platform under its LifeLearn Brand

LifeLearn offers a full suite of website creation, digital marketing, client communications and education, and…

2 hours ago

CORRECTION: TruMerit and NAPNAP Team Up to Develop a Global Micro-credential for Pediatric Nursing Care

PHILADELPHIA, PA / ACCESS Newswire / December 17, 2025 / TruMerit, a worldwide leader in…

2 hours ago